Julia Djonova

Company: Swiss Agency for Therapeutic Products

Job title: Leiterin Advanced Therapy Medicinal Products Professional

Seminars:

Swiss Regulatory Aspects & Evaluation Considerations for mRNA Technology & Future Therapeutic Potential 9:15 am

Swissmedic Innovation Office – Visibility near the innovation, promote innovation Swissmedic’s Competence Center Advanced Therapy Medicinal Products (ATMP): ATMP Risk Based Approach Read more

day: Day Two AM

Panel Discussion: Realising The Impact of mRNA Medicine Perception on Public Health 9:30 am

• Understanding the complexity of the regulatory and scientific classification of innovative RNA products • Gaining perspective on the intersection of public health and regulatory landscape from drug discovery to patient access • What is the value for patients of more granularity in medicine classification? • How can we increase public health benefits of mRNA…Read more

day: Day Two AM